Clinical importance of the Mandalay spitting cobra (Naja mandalayensis) in Upper Myanmar - Bites, envenoming and ophthalmia.
Antivenom
Local necrosis
Naja kaouthia, spitting cobra
Naja mandalayensis
Neurotoxic envenoming
Upper Myanmar
Venom ophthalmia
Journal
Toxicon : official journal of the International Society on Toxinology
ISSN: 1879-3150
Titre abrégé: Toxicon
Pays: England
ID NLM: 1307333
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
10
03
2020
revised:
22
05
2020
accepted:
27
05
2020
pubmed:
7
6
2020
medline:
28
8
2020
entrez:
7
6
2020
Statut:
ppublish
Résumé
Examination of 18 cobras brought to three hospitals in the Mandalay Region by patients bitten or spat at by them distinguished 3 monocled cobras (Naja kaouthia) and 15 Mandalay spitting cobras (N. mandalayensis), based on their morphological characteristics. We confirm and extend the known distributions and habitats of both N. mandalayensis and N. kaouthia in Upper Myanmar. Clinical symptoms of local and systemic envenoming by N. mandalayensis are described for the first time. These included local swelling, blistering and necrosis and life-threatening systemic neurotoxicity. More information is needed about the clinical phenotype and management of bites by N. mandalayensis, the commoner of the two cobras in Upper Myanmar. Since the current cobra antivenom manufactured in Myanmar has lower pre-clinical efficacy against N. mandalayensis than N. kaouthia, there is a need for more specific antivenom therapy.
Identifiants
pubmed: 32504626
pii: S0041-0101(20)30254-3
doi: 10.1016/j.toxicon.2020.05.023
pii:
doi:
Substances chimiques
Antivenins
0
Elapid Venoms
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
39-47Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.